Literature DB >> 1468866

The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.

C Miller1, C P Farrington, K Harbert.   

Abstract

Two hundred and ninety cases of subacute sclerosing panencephalitis (SSPE) registered in England and Wales from 1970 to 1989 were followed at 6-monthly intervals. Male to female ratio was 2.8:1. Age at onset increased significantly over the period. Measles was recorded for 81% of cases; in nearly half this had occurred under 2 years. Measles vaccine was documented in 20 cases; in 10 measles was also documented and it could not be positively excluded in the remainder. The calculated risk of SSPE following measles was 4.0/100,000 cases compared with the risk after vaccine of 0.14/100,000 doses. Measles under 1 year carried a risk 16 times greater than measles over 5 years. There was an excess of cases in third and subsequent children. The incidence was higher in the northwest than in the southeast of the country. Survival time varied from 4 weeks to 16 years and was shorter when measles had occurred over the mean age of 2.5 years. Of the cases 9% had a history of mental retardation before the onset of SSPE. The incidence of SSPE has fallen following the reduction in measles resulting from vaccination. However, because of the median 8-year interval between measles and onset of SSPE, further cases arising from measles during the study period must still be expected, particularly in adolescents.

Entities:  

Mesh:

Year:  1992        PMID: 1468866     DOI: 10.1093/ije/21.5.998

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  16 in total

Review 1.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

Review 2.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

3.  Rare disease surveillance: An international perspective.

Authors:  E J Elliott; A Nicoll; R Lynn; V Marchessault; R Hirasing; G Ridley
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

4.  Rapid neurological deterioration in a 22-year-old man.

Authors:  M O McCarron; G V McDonnell; J M Gibson
Journal:  Postgrad Med J       Date:  1997-06       Impact factor: 2.401

5.  A 29-year-old pregnant woman with worsening left hemiparesis, encephalopathy, and hemodynamic instability: a case report of subacute sclerosing panencephalitis.

Authors:  Gerald F Reis; Jana M Ritter; William J Bellini; Paul A Rota; Andrew W Bollen
Journal:  Clin Neuropathol       Date:  2015 Sep-Oct       Impact factor: 1.368

6.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.

Authors:  C Miller; N Andrews; M Rush; H Munro; L Jin; E Miller
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

Review 7.  Measles virus-induced suppression of immune responses.

Authors:  Diane E Griffin
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

8.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

9.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

10.  Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy.

Authors:  J Lewin; A P Dhillon; R Sim; G Mazure; R E Pounder; A J Wakefield
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.